AVLN Avalyn Pharma Inc.
$25.83▼ -4.83%
Healthcare
Other
Volume 961.3K
Avg Volume (10D) 334.6K
Key Metrics & Fundamentals
Market Cap
$1.15B
P/E Ratio
–
Div Yield
0.00%
52W Range
22.24 - 40.17
% vs 50 MA
-16.45%
% vs 200 MA
–%
RSI-14
45.0
MACD Histogram
+0.5200
Beta (1Y vs SPY)
-0.06
Free Cash Flow
-$26.35M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$28.55M
COGS
–
Operating Exp
$31.29M
Operating Income
-$31.29M
EBIT
-$31.29M
Pretax Income
-$28.94M
Net Income
-$28.94M
EPS (Diluted)
-0.65
Price & Volume History
Loading chart…
Recent News
Syndax Pharmaceuticals Stock Plunges. A Failed Trial Deals Blow to Growth Plans.
Barrons.com · Oct 13, 2026 11:24 AM ET
Avalyn Pharma (AVLN) Following AP02 Phase 1 Data Is Its Valuation Too Pricey
Simply Wall St. · Sep 23, 2026 5:15 AM ET
Avalyn Publishes Phase 1 Data Highlighting AP02’s Lung-Targeted Delivery and Encouraging Safety Profile
GlobeNewswire · Sep 21, 2026 9:00 AM ET
Avalyn Appoints Robert J. Meyer, MD, to its Board of Directors
GlobeNewswire · Sep 16, 2026 4:01 PM ET
Avalyn to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
GlobeNewswire · Sep 8, 2026 8:00 AM ET
Avalyn Presents New Data at ERS Congress 2026 Supporting AP01 Lung Distribution and Patient-Centered Trial Design in Pulmonary Fibrosis
GlobeNewswire · Sep 8, 2026 8:00 AM ET
Avalyn Announces Multiple Presentations at the European Respiratory Society International Congress 2026
GlobeNewswire · Aug 24, 2026 4:01 PM ET
Avalyn Pharma's Q2 Net Loss Widens
MT Newswires · Aug 12, 2026 8:30 AM ET
Avalyn: Q2 Earnings Snapshot
Associated Press · Aug 12, 2026 8:28 AM ET
Avalyn Reports Second Quarter 2026 Financial Results and Recent Business Highlights
GlobeNewswire · Aug 12, 2026 8:00 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See AVLN's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.